Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure | BioSpace Source Cluster: BioSpace Source Node: 3081002Time Stamp: Jan 22, 2024
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure | BioSpace Source Cluster: BioSpace Source Node: 2984476Time Stamp: Nov 28, 2023
Nanopore sequencing of DNA-barcoded probes for highly multiplexed detection of microRNA, proteins and small biomarkers – Nature Nanotechnology Source Cluster: Nature Nanotechnology Source Node: 2899860Time Stamp: Sep 25, 2023